These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29321644)

  • 1. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
    Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
    Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
    Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
    Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
    BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
    Kundu N; Ma X; Kochel T; Goloubeva O; Staats P; Thompson K; Martin S; Reader J; Take Y; Collin P; Fulton A
    Breast Cancer Res Treat; 2014 Jan; 143(1):19-31. PubMed ID: 24281828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
    Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
    Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
    Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
    Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.
    Pan MR; Hou MF; Chang HC; Hung WC
    J Biol Chem; 2008 Apr; 283(17):11155-63. PubMed ID: 18319253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
    Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.
    Karavitis J; Hix LM; Shi YH; Schultz RF; Khazaie K; Zhang M
    PLoS One; 2012; 7(9):e46342. PubMed ID: 23029485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer.
    Hunter S; Nault B; Ugwuagbo KC; Maiti S; Majumder M
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
    Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
    Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM
    Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.